2,528 Shares of HCA Healthcare, Inc. $HCA Bought by Canandaigua National Trust Co of Florida

Key Points

• Canandaigua National Trust Co. of Florida initiated a position in HCA Healthcare by purchasing 2,528 shares valued at approximately $1.08 million. Institutional investors collectively own 62.73% of the company.
• HCA shares rose 1.5% to $438.56, while the company reported quarterly revenue of $20.23 billion and earnings of $7.59 per share, exceeding analyst expectations.
• Analysts maintain a consensus “Moderate Buy” rating with an average price target of $466.35. HCA also pays a quarterly dividend of $0.78, representing a 0.7% annualized yield.

Canandaigua National Trust Co of Florida bought a new position in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 2,528 shares of the company's stock, valued at approximately $1,079,000.

Several other institutional investors and hedge funds also recently bought and sold shares of HCA. Sunbelt Securities Inc. raised its holdings in HCA Healthcare by 171.7% during the 1st quarter. Sunbelt Securities Inc. now owns 6,242 shares of the company's stock valued at $2,954,000 after acquiring an additional 3,945 shares during the period. Arrowstreet Capital Limited Partnership raised its stake in shares of HCA Healthcare by 11.9% during the 4th quarter. Arrowstreet Capital Limited Partnership now owns 2,311,112 shares of the company's stock valued at $1,078,966,000 after purchasing an additional 245,887 shares during the period. Sei Investments Co. boosted its stake in HCA Healthcare by 27.5% in the 1st quarter. Sei Investments Co. now owns 467,796 shares of the company's stock worth $221,380,000 after purchasing an additional 100,764 shares during the period. Oddo BHF Asset Management Sas increased its position in shares of HCA Healthcare by 40.8% during the fourth quarter. Oddo BHF Asset Management Sas now owns 9,760 shares of the company's stock valued at $4,557,000 after buying an additional 2,829 shares during the period. Finally, SEB Asset Management AB bought a new position in shares of HCA Healthcare in the first quarter valued at approximately $75,534,000. 62.73% of the stock is owned by institutional investors.

HCA Healthcare Trading Up 1.5%

Shares of HCA traded up $6.36 during midday trading on Wednesday, reaching $438.56. The stock had a trading volume of 998,798 shares, compared to its average volume of 1,347,548. The company has a market capitalization of $94.95 billion, a price-to-earnings ratio of 14.68, a price-to-earnings-growth ratio of 1.47 and a beta of 1.10. HCA Healthcare, Inc. has a 12-month low of $353.99 and a 12-month high of $556.52. The company's 50-day moving average is $418.32 and its 200 day moving average is $420.54.

HCA Healthcare (NYSE:HCA - Get Free Report) last released its earnings results on Friday, July 24th. The company reported $7.59 earnings per share for the quarter, topping analysts' consensus estimates of $7.56 by $0.03. The company had revenue of $20.23 billion during the quarter, compared to the consensus estimate of $19.76 billion. HCA Healthcare had a negative return on equity of 244.79% and a net margin of 8.77%.HCA Healthcare's quarterly revenue was up 8.7% compared to the same quarter last year. During the same quarter in the previous year, the company posted $6.84 EPS. Research analysts forecast that HCA Healthcare, Inc. will post 29.42 EPS for the current fiscal year.

HCA Healthcare Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, September 30th. Shareholders of record on Wednesday, September 16th were paid a $0.78 dividend. The ex-dividend date of this dividend was Wednesday, September 16th. This represents a $3.12 annualized dividend and a yield of 0.7%. HCA Healthcare's payout ratio is currently 10.45%.

Wall Street Analysts Forecast Growth

Several analysts have issued reports on the stock. Leerink Partners reiterated an "outperform" rating and issued a $492.00 target price on shares of HCA Healthcare in a research note on Friday, September 18th. Truist Financial decreased their price target on shares of HCA Healthcare from $535.00 to $495.00 and set a "buy" rating on the stock in a report on Monday, July 27th. Barclays reduced their target price on HCA Healthcare from $402.00 to $387.00 and set an "equal weight" rating for the company in a research report on Monday, July 27th. Morgan Stanley lowered their price target on HCA Healthcare from $425.00 to $380.00 and set an "underweight" rating on the stock in a report on Monday, July 27th. Finally, Sanford C. Bernstein restated a "market perform" rating on shares of HCA Healthcare in a research report on Wednesday, July 15th. Fifteen analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, HCA Healthcare presently has a consensus rating of "Moderate Buy" and an average target price of $466.35.

HCA Healthcare Profile

HCA Healthcare, Inc is a provider of healthcare services in the United States. Through its network of hospitals and other healthcare facilities, the company delivers services including emergency and urgent care, surgery, inpatient and outpatient treatment, women's and children's care, cardiology, oncology, orthopedics, and behavioral health services.

HCA Healthcare also operates physician practices, ambulatory surgery centers, freestanding emergency rooms, diagnostic facilities, and other outpatient care sites.

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.